References
- Scanlon ML, Vreeman RC. Current strategies for improving access and adherence to antiretroviral therapies in resource-limited settings. HIV AIDS. 2013;5:1-17. PubMed | Google Scholar
- Evans SR, Ellis RJ, Chen H, Yeh T, Lee AJ, Schifitto G et al. Peripheral neuropathy in HIV: prevalence and risk factors. AIDS. 2011; 25(7): 919-28. PubMed | Google Scholar
- Keswani SC, Pardo CA, Cherry CL, Hoke A, McArthur JC. HIV-associated sensory neuropathies. AIDS. 2002; 16(16):2105-17. PubMed | Google Scholar
- Wulff EA, Wang AK, Simpson DM. HIV-associated peripheral neuropathy: epidemiology, pathophysiology, and treatment. Drugs. 2000;59(6):1251-60. PubMed | Google Scholar
- Kamerman PR, Wadley AL, Cherry CL. HIV-associated sensory neuropathy: Risk factors and genetics. Curr Opin Clin Nutr Metab Care. 2012 Jun;16(3):226-36. PubMed | Google Scholar
- National AIDS Control Council. Kenya AIDS Response Progress Report Progress towards Zero. Nascop, Minist Heal Gov Kenya. 2014; (March):37. PubMed | Google Scholar
- Hawkins C, Achenbach C, Fryda W, Ngare D, Murphy R. Antiretroviral durability and tolerability in HIV-infected adults living in urban Kenya. J Acquir Immune Defic Syndr. 2007; 45(3):304-10. PubMed | Google Scholar
- Forna F, Liechty CA, Solberg P, Asiimwe F, Were W, Mermin J et al. Clinical toxicity of highly active antiretroviral therapy in a home-based AIDS care program in rural Uganda. J Acquir Immune Defic Syndr. 2007; 44(4): 456-62. PubMed | Google Scholar
- Maritz J, Benatar M, Dave JA, Harrison TB, Badri M, Levitt NS et al. HIV neuropathy in South Africans: frequency, characteristics, and risk factors. Muscle Nerve. 2010;41(5): 599-606. PubMed | Google Scholar
- Cherry CL, Skolasky RL, Lal L, Creighton J, Hauer P, Raman SP et al. Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort. Neurology. 2006; 66(6):867-73. PubMed | Google Scholar
- Smyth K, Affandi JS, McArthur JC, Bowtell-Harris C, Mijch AM, Watson K et al. Prevalence of and risk factors for HIV-associated neuropathy in Melbourne, Australia 1993-2006. HIV Med. 2007;8(6):367-73. PubMed | Google Scholar
- Hulgan T, Haas DW, Haines JL, Ritchie MD, Robbins GK, Shafer RW et al. Mitochondrial haplogroups, and peripheral neuropathy during antiretroviral therapy: an adult AIDS clinical trials group study. AIDS. 2005;19(13):1341-9. PubMed | Google Scholar
- Quasney MW, Zhang Q, Sargent S, Mynatt M, Glass J, McArthur J. Increased frequency of the tumor necrosis factor-alpha-308 A allele in adults with human immunodeficiency virus dementia. Ann Neurol. 2001;50(2):157-62. PubMed | Google Scholar
- Price P, Morahan G, Huang D, Stone E, Cheong KYM, Castley A et al. Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases. AIDS. 2002;16(15):2043-7. PubMed | Google Scholar
- Maher B, Alfirevic A, Vilar FJ, Wilkins EGL, Park BK, Pirmohamed M. TNF-alpha promoter region gene polymorphisms in HIV-positive patients with lipodystrophy. AIDS. 2002; 16(15):2013-8. PubMed | Google Scholar
- Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M et al. Prevalence of lower-extremity disease in the US adult population >=40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care. 2004;27(7):1591-7. PubMed | Google Scholar
- Sorensen L, Molyneaux L, Yue DK. Insensate versus painful diabetic neuropathy: the effects of height, gender, ethnicity, and glycaemic control. Diabetes Res Clin Pract. 2002;57(1):45-51. PubMed | Google Scholar
- Gonzalez-Duarte A, Cikurel K, Simpson DM. Managing HIV peripheral neuropathy. Current HIV/AIDS Reports. 2007. p. 114-8. PubMed | Google Scholar
- Affandi JS, Price P, Imran D, Yunihastuti E, Djauzi S, Cherry CL. Can we predict neuropathy risk before stavudine prescription in a resource-limited setting?. AIDS Res Hum Retroviruses. 2008;24(10):1281-4. PubMed | Google Scholar
- Cherry CL, Affandi JS, Imran D, Yunihastuti E, Smyth K, Vanar S et al. Age and height predict neuropathy risk in patients with HIV prescribed stavudine. Neurology. 2009;73(4):315-20. PubMed | Google Scholar
- Wadley AL, Cherry CL, Price P, Kamerman PR. HIV neuropathy risk factors and symptom characterization in stavudine-exposed South Africans. J Pain Symptom Manage. 2011;41(4):700-6. PubMed | Google Scholar
- Mehta SA, Ahmed A, Laverty M, Holzman RS, Valentine F, Sivapalasingam S. Sex differences in the incidence of peripheral neuropathy among Kenyans initiating antiretroviral therapy. Clin Infect Dis. 2011;53(5):490-6. PubMed | Google Scholar
- Tseng C-H. Prevalence of lower-extremity amputation among patients with diabetes mellitus: is height a factor?. CMAJ. 2006;174(3):319-23. PubMed | Google Scholar
- Cheng YJ, Gregg EW, Kahn HS, Williams DE, De Rekeneire N, Narayan KMV. Peripheral insensate neuropathy-A tall problem for US adults?. Am J Epidemiol. 2006;164(9):873-80. PubMed | Google Scholar
- Nyati LH, Norris SA, Cameron N, Pettifor JM. Effect of ethnicity and sex on the growth of the axial and appendicular skeleton of children living in a developing country. Am J Phys Anthropol. 2006;130(1):135-41. PubMed | Google Scholar
- Fowke KR, Nagelkerke NJ, Kimani J, Simonsen JN, Anzala AO, Bwayo JJ et al. Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet. 1996;348(9038):1347-51. PubMed | Google Scholar
- World Health Organization. Physical status: the use and interpretation of anthropometry. Report of a WHO expert committee, WHO Technical Report Series 854, WHO, 1995; Geneva. Google Scholar
- World Health Organization. Antiretroviral therapy for HIV-1 infection in adults and adolescents. WHO, 2010; Geneva. Google Scholar
- World Health Organization. Rapid advice: Antiretroviral therapy for HIV infection in adults and adolescents. WHO, 2009; Geneva. Google Scholar
- Ellis RJ, Rosario D, Clifford DB, McArthur JC, Simpson D, Alexander T et al. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study. Arch Neurol. 2010;67(5):552-8. PubMed | Google Scholar
- Luma HN, Tchaleu BCN, Doualla MS, Temfack E, Sopouassi VNK, Mapoure YN et al. HIV-associated sensory neuropathy in HIV-1 infected patients at the Douala General Hospital in Cameroon: a cross-sectional study. AIDS Res Ther. 2012;9(1):35. PubMed | Google Scholar
- Fauci AS, Pantaleo G, Stanley S, Weissman D. Immunopathogenic mechanisms of HIV infection. Ann Intern Med. 1996;124(7):654-63. PubMed | Google Scholar
- Sacktor N. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J Neurovirol. 2002; 8 Suppl 2:115-21. PubMed | Google Scholar
- Westreich DJ, Sanne I, Maskew M, Malope-Kgokong B, Conradie F, Majuba P et al. Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy. Clin Infect Dis. 2009; 48(11):1617-23. PubMed | Google Scholar
- Cettomai D, Kwasa J, Kendi C, Birbeck GL, Price RW, Bukusi EA et al. Utility of quantitative sensory testing and screening tools in identifying HIV-associated peripheral neuropathy in Western Kenya: pilot testing. PLoS One. 2010; 5(12):e14256. PubMed | Google Scholar
- Mehta SA, Ahmed A, Kariuki BW, Said S, Omasete F, Mendillo M, et al. Implementation of a validated peripheral neuropathy screening tool in patients receiving antiretroviral therapy in Mombasa, Kenya. Am J Trop Med Hyg. 2010;83(3):565-70. PubMed | Google Scholar
- Evans D, Takuva S, Rassool M, Firnhaber C, Maskew M. Prevalence of peripheral neuropathy in antiretroviral therapy naive HIV-positive patients and the impact on treatment outcomes-a retrospective study from a large urban cohort in Johannesburg, South Africa. J Neurovirol. 2012;18(3):162-71. PubMed | Google Scholar
- Polydefkis M, Hauer P, Sheth S, Sirdofsky M, Griffin JW, McArthur JC. The time course of epidermal nerve fibre regeneration: studies in normal controls and in people with diabetes, with and without neuropathy. Brain. 2004;127(Pt 7):1606-15. PubMed | Google Scholar
- Tumusiime DK, Venter F, Musenge E, Stewart A. Prevalence of peripheral neuropathy and its associated demographic and health status characteristics, among people on antiretroviral therapy in Rwanda. BioMed Central. 2014;14(1):1306. PubMed | Google Scholar
- Tumusiime DK, Musabeyezu E, Mutimurah E, Hoover DR, Shi Q, Rudakemwa E et al. Over-reported peripheral neuropathy symptoms in a cohort of HIV infected and uninfected Rwandan women: the need for validated locally appropriate questionnaires. Afr Health Sci. 2014;14(2):460-7. PubMed | Google Scholar
- Millogo A, Lankoandé D, Yameogo I, Yaméogo AA, Sawadogo AB. Polyneuropathies in patients treated with HAART in Bobo-Dioulasso hospital, Burkina Faso. Bull Soc Pathol Exot. 2008;101(1):11-3. PubMed | Google Scholar
- Mateo MG, Gutierrez M del M, Vidal F, Domingo P. Stavudine extended release (once-daily, Bristol-Myers Squibb) for the treatment of HIV/AIDS. Expert Opin Pharmacother. 2013;14(8):1055-64. PubMed | Google Scholar
- Banerjee S, McCutchan JA, Ances BM, Deutsch R, Riggs PK, Way L et al. Hypertriglyceridemia in combination antiretroviral-treated HIV-positive individuals: potential impact on HIV sensory polyneuropathy. AIDS. 2011;25(2):F1-6. PubMed | Google Scholar
- Moore RD, Wong WM, Keruly JC, McArthur JC. Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine, and hydroxyurea. AIDS. 2000;14(3):273-8. PubMed | Google Scholar
- Breen RA, Lipman MC, Johnson MA. Increased incidence of peripheral neuropathy with co-administration of stavudine and isoniazid in HIV-infected individuals. AIDS. 2000;14(5):615. PubMed | Google Scholar
- Cornblath DR, Hoke A. Recent advances in HIV neuropathy. Curr Opin Neurol. 2006;19(5):446-50. PubMed | Google Scholar
- Childs EA, Lyles RH, Selnes OA, Chen B, Miller EN, Cohen BA et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology. 1999;52(3):607-13. PubMed | Google Scholar
- Tagliati M, Grinnell J, Godbold J, Simpson DM. Peripheral nerve function in HIV infection: clinical, electrophysiologic, and laboratory findings. Arch Neurol. 1999;56(1):84-9. PubMed | Google Scholar
- England JD, Gronseth GS, Franklin G, Carter GT, Kinsella LJ, Cohen JA et al. Practice Parameter: evaluation of distal symmetric polyneuropathy: role of laboratory and genetic testing (an evidence-based review). Report of the American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine and Am Neurology. 2009;72(2):185-92. PubMed | Google Scholar
- Finnerup NB, Haroutounian S, Kamerman P, Baron R, Bennett DLH, Bouhassira D et al. Neuropathic pain: An updated grading system for research and clinical practice. Lancet Neurol. 2016;15(3):245. PubMed | Google Scholar